insights_auto
Why is ISI down 2.13%?
Dive Deeperchevron_right
ISI:FRA
Ionis Pharmaceuticals Inc
€38.21
arrow_downward
-2.13%(-0.83) 1D
Oct 19, 8:00:18 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ISI...
Open
€38.21
High
€38.21
Low
€38.21
Mkt. cap
7.36B
Avg. vol.
87.00
Volume
0.00
52-wk high
€75.00
52-wk low
€37.57
No. of employees
1K
Open
€38.21
High
€38.21
Low
€38.21
Mkt. cap
7.36B
Avg. vol.
87.00
Volume
0.00
52-wk high
€75.00
52-wk low
€37.57
No. of employees
1K
News stories
From web sources and news partners
Investing.com UK
·
8 hours ago
InvestingPro Fair Value flagged Ionis stock before 48% plunge By Investing.com
Simply Wall Street
·
13 hours ago
Ionis Pharmaceuticals (IONS) Shares Dropped, So What Is Behind The Latest Attention?
Simply Wall Street
·
2 days ago
Did EU Backing Just Shift Ionis Pharmaceuticals (IONS) Investment Narrative?
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com